Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-12

Clinical Trial Update: Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating telemetric glucose data acquisition during initiation of insulin pump therapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Insulin-Dependent | Phase 2 | Status: WITHDRAWN